StockNews.AI
SRPT
StockNews.AI
119 days

Sarepta Therapeutics to Announce First Quarter 2025 Financial Results

1. Sarepta Therapeutics will report Q1 2025 results on May 6, 2025. 2. A conference call will provide insights into financial performance post-report.

Earnings
+7.73%Current Return
VS
+4.22%S&P 500
$55.2304/22 08:36 AM EDTEvent Start
$59.504/23 03:14 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Neutral?

Upcoming earnings report is standard; unusual movements may depend on results.

How important is it?

Earnings reports can influence stock prices; however, current news lacks specific performance indicators.

Why Short Term?

Market reaction will be immediate after earnings release on May 6.

Related Companies

SRPTVRTXEDIT
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report first quarter 2025 financial results after the Nasdaq Global Market closes on Tuesday, May 6, 2025. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its first quarter 2025 financial results. The event will be webcast live under the investor relations section of Sarepta's website at https://investorrelations.sarept.

Related News